Preclinical Studies: Once-weekly GLP1 patch

Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs

DECEMBER 19 2024

​

Business Wire

​​

Successful GLP-1 Data

Anodyne Presents Successful Preclinical Data of a Once-Weekly GLP-1RA Patch at PODD 2024 in Boston, MA

OCTOBER 25 2024

​​

Board of Directors

Anodyne Nanotech, Inc. Appoints Jeff Mihm to its Board of Directors.

FEBRUARY 6 2023

​

Business Wire

Publication

Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.

​

Nature Scientific Reports

FEBRUARY 3 2022

​

Nature

MLSC Funding

Baker-Polito Administration Announces $18 Million in Life Sciences Capital Funding to Support Research Infrastructure, Data Science, and Drug Delivery Projects​

JULY  8 2021

​

Massachusetts Life Sciences Center

Seed Financing

Boston Biotech, Anodyne Nanotech Advances the Hero Patch Platform by Securing $4.2M in Seed Financing

​

APRIL 8 2021

​

News Direct

Publication

Low-cost and cleanroom-free fabrication of microneedles.

​

Nature Journal, Microsystems and Nanoengineering.

JANUARY 15 2018

​

Nature